HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 50008,
"recordsTotal": 50008,
"next": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=-status&start=48300",
"previous": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=-status&start=47700",
"results": [
{
"registry_id": "NCT07574593",
"publication_url": "https://clinicaltrials.gov/study/NCT07574593",
"title": "NORM-HF (NORM-guided Congestion Management in Heart Failure) Pivotal Study",
"has_exemption": false,
"start_date": "2026-05-29",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Foundry Innovation & Research 1, Limited (FIRE1)",
"sponsor_slug": "foundry-innovation-research-1-limited-fire1",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06465290",
"publication_url": "https://clinicaltrials.gov/study/NCT06465290",
"title": "Promoting Neuroplastic Changes of Patients With TBI",
"has_exemption": false,
"start_date": "2026-07-16",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, Baltimore",
"sponsor_slug": "university-of-maryland-baltimore",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07656415",
"publication_url": "https://clinicaltrials.gov/study/NCT07656415",
"title": "A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease",
"has_exemption": false,
"start_date": "2026-07-21",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Agios Pharmaceuticals, Inc.",
"sponsor_slug": "agios-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07680127",
"publication_url": "https://clinicaltrials.gov/study/NCT07680127",
"title": "Transcutaneous Auricular Vagal Nerve Stimulation for Treatment of Radiation Necrosis",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07682662",
"publication_url": "https://clinicaltrials.gov/study/NCT07682662",
"title": "Evaluation of a Standardized Low-Dose Bolus Ketamine Pathway for Management of Pediatric Sickle Cell Patients Presenting to the Emergency Department With Pain",
"has_exemption": false,
"start_date": "2026-08-01",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Mississippi Medical Center",
"sponsor_slug": "university-of-mississippi-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05422469",
"publication_url": "https://clinicaltrials.gov/study/NCT05422469",
"title": "Neurobehavioral Investigations of Approach Dynamics in the Ventral Striatum",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor College of Medicine",
"sponsor_slug": "baylor-college-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07212998",
"publication_url": "https://clinicaltrials.gov/study/NCT07212998",
"title": "Plasma Resuscitation Early for Evaluating Volume and Endotheliopathy of Thermal Injury (PREEVEnT) Trial",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jason Sperry",
"sponsor_slug": "jason-sperry",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07277738",
"publication_url": "https://clinicaltrials.gov/study/NCT07277738",
"title": "Precision Supplemental Imaging in Women With Dense Breasts (PSID Trial)",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07694986",
"publication_url": "https://clinicaltrials.gov/study/NCT07694986",
"title": "Phase 2 Trial With a Safety Run-in of Combinatorial Therapies With Intrathecal (IT) Dendritic Cell Vaccines (cDC1s) inHER+ (Combined With IT Trastuzumab) and HER2- (Combined With IT Nivolumab) Breast Cancer (BC) Leptomeningeal Disease (LMD)",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07706166",
"publication_url": "https://clinicaltrials.gov/study/NCT07706166",
"title": "An Interventional Study of Letermovir for Primary Prophylaxis of Cytomegalovirus Infection in Moderate Risk (R+) Abdominal Solid Organ Transplant Recipients",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07713459",
"publication_url": "https://clinicaltrials.gov/study/NCT07713459",
"title": "A Phase II Single Arm, Open Label Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kure Cells, INC",
"sponsor_slug": "kure-cells-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07732634",
"publication_url": "https://clinicaltrials.gov/study/NCT07732634",
"title": "RiMO-HNC-NEO1: Phase 2 Study of RiMO-301 and Hypofractionated Radiotherapy With Pembrolizumab for the Neoadjuvant Treatment of Resectable, Locally Advanced Head-Neck Cancer",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07750496",
"publication_url": "https://clinicaltrials.gov/study/NCT07750496",
"title": "Study Testing Outcomes After Planned Discontinuation of AntiSeizure Medication",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05647811",
"publication_url": "https://clinicaltrials.gov/study/NCT05647811",
"title": "A Phase Ib, Open Label, Dose Escalation Study of NM8074 in Subjects With C3 Glomerulopathy (C3G)",
"has_exemption": false,
"start_date": "2027-05-31",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NovelMed Therapeutics",
"sponsor_slug": "novelmed-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06940570",
"publication_url": "https://clinicaltrials.gov/study/NCT06940570",
"title": "A Randomized Single Center Trial to Determine the Efficacy of Methadone as a First Line Agent in the Reduction and Treatment of Pain in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation",
"has_exemption": false,
"start_date": "2028-01-01",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04770870",
"publication_url": "https://clinicaltrials.gov/study/NCT04770870",
"title": "Post Approval Study 2: Hintermann Series H3 Total Ankle Replacement System",
"has_exemption": false,
"start_date": "2022-02-01",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "DT MedTech, LLC",
"sponsor_slug": "dt-medtech-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05963698",
"publication_url": "https://clinicaltrials.gov/study/NCT05963698",
"title": "The Fourth Left Atrial Appendage Occlusion Study (LAAOS-4)",
"has_exemption": false,
"start_date": "2023-11-30",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Hamilton Health Sciences Corporation",
"sponsor_slug": "hamilton-health-sciences-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06586021",
"publication_url": "https://clinicaltrials.gov/study/NCT06586021",
"title": "SEAL - Safety & Feasibility Evaluation of the Aortoseal™ for Seal and Fixation of Abdominal Aortic Aneurysms (AAA) Endovascular Grafts to the Aortic Wall\"",
"has_exemption": false,
"start_date": "2024-02-06",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Endoron Medical",
"sponsor_slug": "endoron-medical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06722391",
"publication_url": "https://clinicaltrials.gov/study/NCT06722391",
"title": "Neuromuscular Electrical Stimulation: A Novel Treatment for Improving Metabolism",
"has_exemption": false,
"start_date": "2024-08-19",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas, El Paso",
"sponsor_slug": "university-of-texas-el-paso",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06525740",
"publication_url": "https://clinicaltrials.gov/study/NCT06525740",
"title": "Methadone Versus Intrathecal Hydromorphone for Postoperative Analgesia in Patients Undergoing Surgery for Gynecologic Malignancy Via Midline Laparotomy Receiving Liposomal Bupivacaine",
"has_exemption": false,
"start_date": "2024-09-03",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06580041",
"publication_url": "https://clinicaltrials.gov/study/NCT06580041",
"title": "Precision Care for Major Depressive Disorder",
"has_exemption": false,
"start_date": "2024-11-12",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06483061",
"publication_url": "https://clinicaltrials.gov/study/NCT06483061",
"title": "Ferumoxytol Enhanced Hippocampal Vascular Imaging in Epilepsy",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alberta",
"sponsor_slug": "university-of-alberta",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06645613",
"publication_url": "https://clinicaltrials.gov/study/NCT06645613",
"title": "Precision TMS With Integrated Visualization and Analysis of Real-time E-field and EEG Source Imaging",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07515768",
"publication_url": "https://clinicaltrials.gov/study/NCT07515768",
"title": "Transcatheter Aortic Valve Implantation Without On-Site Cardiac Surgery in Poland: Protocol for a Multicenter Prospective Randomized Open-label Clinical Trial",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of Warsaw",
"sponsor_slug": "medical-university-of-warsaw",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07615075",
"publication_url": "https://clinicaltrials.gov/study/NCT07615075",
"title": "Randomized Double-Blind Clinical Trial of an IL-23 Inhibitor for Immune Activation in People With Schizophrenia",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, Baltimore",
"sponsor_slug": "university-of-maryland-baltimore",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07658976",
"publication_url": "https://clinicaltrials.gov/study/NCT07658976",
"title": "Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy of HIV PrEP and STI PEP for Young Men",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "HIV Prevention Trials Network",
"sponsor_slug": "hiv-prevention-trials-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07204080",
"publication_url": "https://clinicaltrials.gov/study/NCT07204080",
"title": "Phase II Clinical Trial Evaluating the Safety Efficacy of Fc-Modified Anti-CD154 mAB (TNX-1500) in Kidney Transplant Recipients",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Ayman Al Jurdi, MD",
"sponsor_slug": "ayman-al-jurdi-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07761117",
"publication_url": "https://clinicaltrials.gov/study/NCT07761117",
"title": "A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Study to Evaluate the Effect of Elecoglipron in Reducing Cardiovascular Outcomes in Participants With HFpEF and HFmrEF (Elevate-HF)",
"has_exemption": false,
"start_date": "2026-08-28",
"completion_date": "2029-09-03",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07650916",
"publication_url": "https://clinicaltrials.gov/study/NCT07650916",
"title": "A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Cabotegravir Ultra Long-acting Plus Rilpivirine Ultra Long-acting or Cabotegravir Long-acting Plus Rilpivirine Long-acting in Adults and Adolescents With HIV Who Are Virologically Suppressed on ART",
"has_exemption": false,
"start_date": "2026-06-25",
"completion_date": "2029-09-04",
"has_results": false,
"results_due": false,
"sponsor_name": "ViiV Healthcare",
"sponsor_slug": "viiv-healthcare",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07723976",
"publication_url": "https://clinicaltrials.gov/study/NCT07723976",
"title": "A Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Cannabidiol Oral Solution (CBD-OS, JZP926-OS) in Participants Aged 1 Year and Older With Developmental and Epileptic Encephalopathy (DEE)",
"has_exemption": false,
"start_date": "2026-10-30",
"completion_date": "2029-09-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Jazz Pharmaceuticals",
"sponsor_slug": "jazz-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07187375",
"publication_url": "https://clinicaltrials.gov/study/NCT07187375",
"title": "A Phase 2, Open-Label Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Pharmacodynamics of Crinecerfont in Pediatric Subjects 0 to <2 Years of Age With Congenital Adrenal Hyperplasia",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2029-09-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurocrine Biosciences",
"sponsor_slug": "neurocrine-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07694427",
"publication_url": "https://clinicaltrials.gov/study/NCT07694427",
"title": "A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan With or Without Bevacizumab in Comparison to Active Observation With or Without Bevacizumab as Maintenance Treatment in Participants With Newly Diagnosed FIGO Stage III/IV Non-Homologous Recombination Deficient Ovarian Cancer",
"has_exemption": false,
"start_date": "2026-10-09",
"completion_date": "2029-09-06",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04994717",
"publication_url": "https://clinicaltrials.gov/study/NCT04994717",
"title": "Phase 3 Randomized, Controlled Study of Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia With Safety Run-in (Golden Gate Study)",
"has_exemption": false,
"start_date": "2021-11-02",
"completion_date": "2029-09-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05827081",
"publication_url": "https://clinicaltrials.gov/study/NCT05827081",
"title": "A Phase IIIb Study to Characterize the Efficacy and Safety of Adjuvant Ribociclib Plus Endocrine Therapy in a Close-to-clinical Practice Patient Population With HR+ HER2- Early Breast Cancer (Adjuvant WIDER)",
"has_exemption": false,
"start_date": "2024-02-28",
"completion_date": "2029-09-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06875310",
"publication_url": "https://clinicaltrials.gov/study/NCT06875310",
"title": "A Randomized, Double-Blind, Phase 3 Trial of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated, Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)",
"has_exemption": false,
"start_date": "2025-04-24",
"completion_date": "2029-09-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Mirati Therapeutics Inc.",
"sponsor_slug": "mirati-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07282613",
"publication_url": "https://clinicaltrials.gov/study/NCT07282613",
"title": "Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema) s.c. Once Weekly Versus Placebo in Children and Adolescents With Type 2 Diabetes",
"has_exemption": false,
"start_date": "2026-08-04",
"completion_date": "2029-09-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07626411",
"publication_url": "https://clinicaltrials.gov/study/NCT07626411",
"title": "A Phase 3, Randomized, Multicenter, Double-blind Study to Assess Stroke and Systemic Embolism Prevention With REGN7508, a Monoclonal Antibody Against Factor XI, Versus Apixaban in Participants With Atrial Fibrillation (ROXI-EVEREST)",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2029-09-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07746687",
"publication_url": "https://clinicaltrials.gov/study/NCT07746687",
"title": "A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial to Evaluate the Efficacy and Safety of JNJ-95597528 for the Treatment of Adult Participants With Inadequately Controlled Moderate to Severe Asthma",
"has_exemption": false,
"start_date": "2026-09-23",
"completion_date": "2029-09-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06469944",
"publication_url": "https://clinicaltrials.gov/study/NCT06469944",
"title": "A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, and Esophageal Adenocarcinoma): Substudy 06C",
"has_exemption": false,
"start_date": "2024-09-20",
"completion_date": "2029-09-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07700238",
"publication_url": "https://clinicaltrials.gov/study/NCT07700238",
"title": "A Phase 3, Randomized, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Adults With Previously Untreated Primary Immune Thrombocytopenia (ITP).",
"has_exemption": false,
"start_date": "2026-07-20",
"completion_date": "2029-09-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07771439",
"publication_url": "https://clinicaltrials.gov/study/NCT07771439",
"title": "A Parallel Group, Phase 3, Randomized, Open-label, 2-arm Study to Demonstrate the Superiority of Belumosudil Versus Best Available Therapy (BAT) in Participants at Least 12 Years of Age With Chronic Graft Versus Host Disease (cGVHD) Refractory to or Recurrent After 2 to 5 Prior Lines of Systemic Therapy",
"has_exemption": false,
"start_date": "2026-09-07",
"completion_date": "2029-09-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07611357",
"publication_url": "https://clinicaltrials.gov/study/NCT07611357",
"title": "Total-Body [18F]F-AraG PET/CT Imaging to Quantify CNS and Systemic T Cell Involvement in Alzheimer's Disease",
"has_exemption": false,
"start_date": "2026-05-16",
"completion_date": "2029-09-16",
"has_results": false,
"results_due": false,
"sponsor_name": "CellSight Technologies, Inc.",
"sponsor_slug": "cellsight-technologies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05714202",
"publication_url": "https://clinicaltrials.gov/study/NCT05714202",
"title": "A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-Risk Non-Muscle Invasive Bladder Cancer",
"has_exemption": false,
"start_date": "2023-03-23",
"completion_date": "2029-09-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04794101",
"publication_url": "https://clinicaltrials.gov/study/NCT04794101",
"title": "Phase 3 Follow-up Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene",
"has_exemption": false,
"start_date": "2020-12-04",
"completion_date": "2029-09-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07747389",
"publication_url": "https://clinicaltrials.gov/study/NCT07747389",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Fixed Doses of Lumateperone Administered as Monotherapy in Participants With Major Depressive Disorder and an Open-label Long-term Extension Treatment With Lumateperone",
"has_exemption": false,
"start_date": "2026-10-20",
"completion_date": "2029-09-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Intra-Cellular Therapies, Inc.",
"sponsor_slug": "intra-cellular-therapies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07024394",
"publication_url": "https://clinicaltrials.gov/study/NCT07024394",
"title": "A Long-term Follow-up Study to Evaluate the Safety and Efficacy of Ruvometinib Tablets (FCN-159 Tablets) in Pediatric Participants With Neurofibromatosis Type 1",
"has_exemption": false,
"start_date": "2025-06-12",
"completion_date": "2029-09-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.",
"sponsor_slug": "shanghai-fosun-pharmaceutical-industrial-development-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07607925",
"publication_url": "https://clinicaltrials.gov/study/NCT07607925",
"title": "A Phase 1/2 Open-label, Multi-center Study to Evaluate the Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (B-NHL)",
"has_exemption": false,
"start_date": "2026-06-12",
"completion_date": "2029-09-24",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07590934",
"publication_url": "https://clinicaltrials.gov/study/NCT07590934",
"title": "A Phase Ib/II, Open-label, Multi-centre, Platform Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of Multiple Anti-Cancer Agents in Metastatic Prostate Cancer",
"has_exemption": false,
"start_date": "2026-06-03",
"completion_date": "2029-09-25",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04802603",
"publication_url": "https://clinicaltrials.gov/study/NCT04802603",
"title": "Dose-Escalated Spine SbRT (DESSRT) for Localized Metastasis to the Spinal Column",
"has_exemption": false,
"start_date": "2021-03-14",
"completion_date": "2029-09-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Baptist Health South Florida",
"sponsor_slug": "baptist-health-south-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02915198",
"publication_url": "https://clinicaltrials.gov/study/NCT02915198",
"title": "CSP #2002 - Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes (VA-IMPACT)",
"has_exemption": false,
"start_date": "2023-04-03",
"completion_date": "2029-09-28",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00781612",
"publication_url": "https://clinicaltrials.gov/study/NCT00781612",
"title": "An Open-Label, Multicenter Extension Study of Trastuzumab Emtansine Administered as a Single Agent or in Combination With Other Anti-Cancer Therapies in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd-Sponsored Trastuzumab Emtansine Study",
"has_exemption": false,
"start_date": "2008-10-16",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Genentech, Inc.",
"sponsor_slug": "genentech-inc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03624660",
"publication_url": "https://clinicaltrials.gov/study/NCT03624660",
"title": "A Phase II Study of Dose-Escalated Proton-Based Radiation Therapy Delivered With a Simultaneous Integrated Boost (SIB) to Intraprostatic Tumors (IPT) Visible on Pretreatment Magnetic Resonance Image",
"has_exemption": false,
"start_date": "2018-09-24",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03770572",
"publication_url": "https://clinicaltrials.gov/study/NCT03770572",
"title": "Phase I/IIa Gene Transfer Clinical Trial for Juvenile Neuronal Ceroid Lipofuscinosis, Delivering the CLN3 Gene by Self-Complementary AAV9",
"has_exemption": false,
"start_date": "2018-11-13",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Neela Therapeutics",
"sponsor_slug": "neela-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04692181",
"publication_url": "https://clinicaltrials.gov/study/NCT04692181",
"title": "Phase 1b/2a Evaluation of the Safety and Tolerability of SYN-004 in Adult Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Recipients",
"has_exemption": false,
"start_date": "2021-02-15",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Theriva Biologics, Inc.",
"sponsor_slug": "theriva-biologics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05374590",
"publication_url": "https://clinicaltrials.gov/study/NCT05374590",
"title": "A Long-term, Single-Arm, Open-label, Multicenter Trial to Evaluate Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis",
"has_exemption": false,
"start_date": "2022-08-18",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05445323",
"publication_url": "https://clinicaltrials.gov/study/NCT05445323",
"title": "A Phase 1/2 Study of the Safety and Efficacy of LX2006 Gene Therapy in Participants With Cardiomyopathy Associated With Friedreich's Ataxia",
"has_exemption": false,
"start_date": "2022-08-24",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Lexeo Therapeutics",
"sponsor_slug": "lexeo-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05489887",
"publication_url": "https://clinicaltrials.gov/study/NCT05489887",
"title": "A Phase II Study of Naxitamab Added to Induction Therapy for Subjects With Newly Diagnosed High-Risk Neuroblastoma",
"has_exemption": false,
"start_date": "2022-09-14",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Giselle Sholler",
"sponsor_slug": "giselle-sholler",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05405361",
"publication_url": "https://clinicaltrials.gov/study/NCT05405361",
"title": "A Long-term Extension of the ARGX-117-2002 Trial to Evaluate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy",
"has_exemption": false,
"start_date": "2023-01-18",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05633667",
"publication_url": "https://clinicaltrials.gov/study/NCT05633667",
"title": "A Phase 2 Platform Study Evaluating the Safety and Efficacy of Novel Treatment Combinations in Patients With Lung Cancer (VELOCITY-Lung)",
"has_exemption": false,
"start_date": "2023-03-16",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05891821",
"publication_url": "https://clinicaltrials.gov/study/NCT05891821",
"title": "Assessment of the Safety and Efficacy of Balstilimab for the Treatment of Relapsed/Refractory Lymphomas (IMMONC0001)",
"has_exemption": false,
"start_date": "2023-09-01",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Immune Oncology Research Institute",
"sponsor_slug": "immune-oncology-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06465745",
"publication_url": "https://clinicaltrials.gov/study/NCT06465745",
"title": "ATLAS (A Transseptal Left Atrial System for Treatment of Mitral Regurgitation) Pivotal Trial",
"has_exemption": false,
"start_date": "2024-09-03",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "4C Medical Technologies, Inc.",
"sponsor_slug": "4c-medical-technologies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06657859",
"publication_url": "https://clinicaltrials.gov/study/NCT06657859",
"title": "A Phase 2, Open-Label Extension Study to Assess the Safety and Efficacy of GLM101 Administered Intravenously to Participants With PMM2-CDG",
"has_exemption": false,
"start_date": "2024-09-30",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Glycomine, Inc.",
"sponsor_slug": "glycomine-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07095205",
"publication_url": "https://clinicaltrials.gov/study/NCT07095205",
"title": "Central Cholinergic Dysfunction in Depression: PET Imaging of a Novel Treatment Target With [18F]VAT to Assess the Antidepressant Effect of Nicotine",
"has_exemption": false,
"start_date": "2024-10-03",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stony Brook University",
"sponsor_slug": "stony-brook-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06557512",
"publication_url": "https://clinicaltrials.gov/study/NCT06557512",
"title": "A Pilot Trial of Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma (SRS-AIM)",
"has_exemption": false,
"start_date": "2024-12-13",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06526195",
"publication_url": "https://clinicaltrials.gov/study/NCT06526195",
"title": "Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure",
"has_exemption": false,
"start_date": "2024-12-13",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Abbott Medical Devices",
"sponsor_slug": "abbott-medical-devices",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06359041",
"publication_url": "https://clinicaltrials.gov/study/NCT06359041",
"title": "RESET-MG: A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Participants With Generalized Myasthenia Gravis",
"has_exemption": false,
"start_date": "2024-12-17",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Cabaletta Bio",
"sponsor_slug": "cabaletta-bio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06406452",
"publication_url": "https://clinicaltrials.gov/study/NCT06406452",
"title": "A Multi-Center Trial to Assess the Safety and Effectiveness of a Bioresorbable Tracheobronchial Splint in Pediatric Subjects With Clinically Significant Tracheobronchomalacia",
"has_exemption": false,
"start_date": "2025-01-07",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06493552",
"publication_url": "https://clinicaltrials.gov/study/NCT06493552",
"title": "A Modular, Open Label, Randomized Phase II/III Trial to Assess Efficacy of Combining sEphB4-HSA (EphrinB2 Inhibitor) With Immunotherapy Regimens in Patients With EphrinB2-High Solid Tumors",
"has_exemption": false,
"start_date": "2025-03-15",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vasgene Therapeutics, Inc",
"sponsor_slug": "vasgene-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06553885",
"publication_url": "https://clinicaltrials.gov/study/NCT06553885",
"title": "A Phase II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic Colorectal Cancer or Hepatocellular Carcinoma",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06943872",
"publication_url": "https://clinicaltrials.gov/study/NCT06943872",
"title": "A Phase 3 Randomized, Open-Label, Multicenter Study of Sonrotoclax Plus Anti-CD20 Antibody Therapies Versus Venetoclax Plus Rituximab in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
"has_exemption": false,
"start_date": "2025-06-11",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BeOne Medicines",
"sponsor_slug": "beone-medicines",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07151677",
"publication_url": "https://clinicaltrials.gov/study/NCT07151677",
"title": "Pre-Frontal tDCS as a Novel Intervention to Reduce Effects of Post-Stroke Fatigue While Improving Language and Attention in Aphasia",
"has_exemption": false,
"start_date": "2025-08-04",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Syracuse University",
"sponsor_slug": "syracuse-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07145255",
"publication_url": "https://clinicaltrials.gov/study/NCT07145255",
"title": "A Multicenter, Open-label Phase 1/2 Dose Finding, Safety, and Pharmacokinetic Study of MBRC-201, an Antibody-drug Conjugate, in Advanced Refractory Solid Tumors",
"has_exemption": false,
"start_date": "2025-09-03",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "MBrace Therapeutics",
"sponsor_slug": "mbrace-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07091734",
"publication_url": "https://clinicaltrials.gov/study/NCT07091734",
"title": "Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024",
"has_exemption": false,
"start_date": "2025-09-08",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07140679",
"publication_url": "https://clinicaltrials.gov/study/NCT07140679",
"title": "A Phase II Trial of Adjuvant Toripalimab in High Risk Localized Colon Cancer With Mismatch Repair Deficiency",
"has_exemption": false,
"start_date": "2025-09-19",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07151248",
"publication_url": "https://clinicaltrials.gov/study/NCT07151248",
"title": "ELECTRIG: Evaluating Effects of Cranial Electrical Stimulation Therapy With Responsive Imaging in Gulf War Illness Pain and Comorbid Symptoms",
"has_exemption": false,
"start_date": "2025-09-26",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07198529",
"publication_url": "https://clinicaltrials.gov/study/NCT07198529",
"title": "Optical Coherence Tomography for Stent Optimization and Its Impact on Short-Duration Dual Antiplatelet Therapy: A Single-Center, Prospective, Exploratory Study",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Korea University Guro Hospital",
"sponsor_slug": "korea-university-guro-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06933706",
"publication_url": "https://clinicaltrials.gov/study/NCT06933706",
"title": "Losartan to Improve Outcomes After Multi-ligament Knee Injury",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07178145",
"publication_url": "https://clinicaltrials.gov/study/NCT07178145",
"title": "MRI of Epicardial Adipose Tissue Composition: Development of Methods and Application to Heart Failure With Preserved Ejection Fraction",
"has_exemption": false,
"start_date": "2025-11-20",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284784",
"publication_url": "https://clinicaltrials.gov/study/NCT07284784",
"title": "An Open-label Clinical Trial Investigating the Long-term Safety of Buntanetap in Treating Participants With Parkinson's Disease",
"has_exemption": false,
"start_date": "2026-01-09",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Annovis Bio Inc.",
"sponsor_slug": "annovis-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07230288",
"publication_url": "https://clinicaltrials.gov/study/NCT07230288",
"title": "A Phase 2a Multicenter Platform Study of Investigational Products for the Treatment of Adult Subjects With Idiopathic Pulmonary Fibrosis",
"has_exemption": false,
"start_date": "2026-01-23",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06231563",
"publication_url": "https://clinicaltrials.gov/study/NCT06231563",
"title": "Examining Ketamine Effects on Depression, Neuroplasticity, and Inflammation in Veterans With Parkinson's Disease",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07219459",
"publication_url": "https://clinicaltrials.gov/study/NCT07219459",
"title": "A Phase 2b, Randomized, Blinded Trial Investigating the Efficacy and Safety of Visugromab in Combination With Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Participants With Unresectable or Metastatic Hepatocellular Carcinoma and Compensated Liver Function (Child-Pugh A) After Failure of First-Line Treatment That Included an Approved Anti PD-(L)1 Compound (GDFATHER HCC-01)",
"has_exemption": false,
"start_date": "2026-03-19",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "CatalYm GmbH",
"sponsor_slug": "catalym-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07563738",
"publication_url": "https://clinicaltrials.gov/study/NCT07563738",
"title": "A 2-part Phase 1/2 Open-label Trial Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of ODM-212 in Combination With Anti-cancer Therapy in Participants With Advanced Solid Tumours",
"has_exemption": false,
"start_date": "2026-03-27",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Orion Corporation, Orion Pharma",
"sponsor_slug": "orion-corporation-orion-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05842174",
"publication_url": "https://clinicaltrials.gov/study/NCT05842174",
"title": "Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma Through Image-guided Locoregional Therapy",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07569042",
"publication_url": "https://clinicaltrials.gov/study/NCT07569042",
"title": "A Rollover Study to Evaluate the Long-Term Safety and Efficacy of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma Who Completed Study NBM-BMX-003 (the Parent Study)",
"has_exemption": false,
"start_date": "2026-04-20",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Novelwise Pharmaceutical Corporation",
"sponsor_slug": "novelwise-pharmaceutical-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07602582",
"publication_url": "https://clinicaltrials.gov/study/NCT07602582",
"title": "An Annual Dosing Study of Donanemab in Participants Who Completed Donanemab Study AACM",
"has_exemption": false,
"start_date": "2026-05-22",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07629960",
"publication_url": "https://clinicaltrials.gov/study/NCT07629960",
"title": "A Phase 1/2, Open-Label, Dose-Escalation, Dose-Enrichment, and Dose-Expansion Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of BLU-924 (SAR449336) as Monotherapy and Combination Therapy in Participants With Advanced Pancreatic Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer Harboring KRAS Mutations",
"has_exemption": false,
"start_date": "2026-06-04",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Blueprint Medicines Corporation",
"sponsor_slug": "blueprint-medicines-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07605364",
"publication_url": "https://clinicaltrials.gov/study/NCT07605364",
"title": "Mycophenolate Mofetil to Overcome Glioblastoma Resistance to Radiotherapy and Temozolomide",
"has_exemption": false,
"start_date": "2026-06-10",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Alliance for Clinical Trials in Oncology",
"sponsor_slug": "alliance-for-clinical-trials-in-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06660225",
"publication_url": "https://clinicaltrials.gov/study/NCT06660225",
"title": "Towards Closed Loop Deep Brain Stimulation for Treatment of Refractory Obsessive-Compulsive Disorder",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Nader Pouratian",
"sponsor_slug": "nader-pouratian",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07109817",
"publication_url": "https://clinicaltrials.gov/study/NCT07109817",
"title": "Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast Cancer (DETOXp)",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Montefiore Medical Center",
"sponsor_slug": "montefiore-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07464145",
"publication_url": "https://clinicaltrials.gov/study/NCT07464145",
"title": "A Phase 3 Study Evaluating the Efficacy and Safety of NDV-01 in Participants With Non-muscle Invasive Bladder Cancer (RESCUE)",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Relmada Therapeutics, Inc.",
"sponsor_slug": "relmada-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07104916",
"publication_url": "https://clinicaltrials.gov/study/NCT07104916",
"title": "A Pilot Mechanistic RCT of Psilocybin With Mindfulness-based Therapy vs Support for Posttraumatic Stress Disorder (PTSD)",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Anthony P King",
"sponsor_slug": "anthony-p-king",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07531251",
"publication_url": "https://clinicaltrials.gov/study/NCT07531251",
"title": "Phase 3b/4, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Trial to Evaluate the Efficacy and Safety of Daily Subcutaneous Injections of Elamipretide in Patients With Genetically Confirmed Barth Syndrome",
"has_exemption": false,
"start_date": "2026-07-02",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stealth BioTherapeutics Inc.",
"sponsor_slug": "stealth-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07282821",
"publication_url": "https://clinicaltrials.gov/study/NCT07282821",
"title": "Bempedoic Acid Therapy for Polycystic Kidney Disease (BEAT-PKD) Randomized Clinical Trial",
"has_exemption": false,
"start_date": "2026-09-21",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Kenneth Hallows",
"sponsor_slug": "kenneth-hallows",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07526948",
"publication_url": "https://clinicaltrials.gov/study/NCT07526948",
"title": "Vaginal Estradiol Versus Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms, Dysbiosis and Markers of Latency Reversal in Menopausal Women Living With HIV",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Albert Einstein College of Medicine",
"sponsor_slug": "albert-einstein-college-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07569965",
"publication_url": "https://clinicaltrials.gov/study/NCT07569965",
"title": "Phase II Multicenter Trial of MB-CART2019.1 (Zamtocabtagene Autoleucel) Therapy as Frontline Consolidation for High-Risk Mantle Cell Lymphoma",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Miltenyi Biomedicine GmbH",
"sponsor_slug": "miltenyi-biomedicine-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07687485",
"publication_url": "https://clinicaltrials.gov/study/NCT07687485",
"title": "Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement System",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Laplace Interventional, Inc",
"sponsor_slug": "laplace-interventional-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07700043",
"publication_url": "https://clinicaltrials.gov/study/NCT07700043",
"title": "Noise Reduction With Hearing Aids",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07722741",
"publication_url": "https://clinicaltrials.gov/study/NCT07722741",
"title": "IMPACT31: A Randomized Open-label, Multi-center, Phase II Adjuvant Study of a Personalized Neoantigen DNA Vaccine (GNOS-PV02) and Plasmid Encoded IL-12 (INO-9012) Versus Active Surveillance in Subjects With High-Risk HCC",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Geneos Therapeutics",
"sponsor_slug": "geneos-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07767825",
"publication_url": "https://clinicaltrials.gov/study/NCT07767825",
"title": "Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Fetuses With Severe Congenital Diaphragmatic Hernia (CDH)",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07739537",
"publication_url": "https://clinicaltrials.gov/study/NCT07739537",
"title": "Polygenic Assessment and Testing of Heterogeneity and Subtypes in Type 2 Diabetes (PATHS-T2D): A Recall-by-Genotype Study of Physiologic and Pharmacologic Responses",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07437963",
"publication_url": "https://clinicaltrials.gov/study/NCT07437963",
"title": "Phase 1/2 Study of Dinutuximab/Cyclophosphamide/Topotecan/Sargramostim (GM-CSF) With or Without Iberdomide in Children With Relapsed, Refractory, or Progressive Neuroblastoma Following Prior Chemoimmunotherapy",
"has_exemption": false,
"start_date": "2026-10-28",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07743541",
"publication_url": "https://clinicaltrials.gov/study/NCT07743541",
"title": "A Multicenter Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, and Efficacy of the NaPi2B Antibody-Drug Conjugate TUB-040 in Patients With Recurrent or Progressive Uterine Endometrial Cancer After Platinum-Based Chemotherapy and Immune Checkpoint Inhibitor Therapy",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Tubulis GmbH",
"sponsor_slug": "tubulis-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07557134",
"publication_url": "https://clinicaltrials.gov/study/NCT07557134",
"title": "A Multi-center, Randomized, No Treatment, Concurrent Controlled Study of E-CEL UVEC CELLS for the Treatment of Perianal Fistula",
"has_exemption": false,
"start_date": "2027-05-31",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Angiocrine Bioscience",
"sponsor_slug": "angiocrine-bioscience",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06465706",
"publication_url": "https://clinicaltrials.gov/study/NCT06465706",
"title": "A Prospective, Multicenter, Randomized Controlled Trial Assessing the Safety and Efficacy of the LAmbre™ Plus Left Atrial Appendage Closure System to REDUCE the Risk of Thromboembolism in Patients With Non-Valvular Atrial Fibrillation",
"has_exemption": false,
"start_date": "2024-09-01",
"completion_date": "2029-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Kansas City Heart Rhythm Research Foundation",
"sponsor_slug": "kansas-city-heart-rhythm-research-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06306638",
"publication_url": "https://clinicaltrials.gov/study/NCT06306638",
"title": "A Phase I/II Study of Interstitial Photodynamic Therapy Following Palliative Radiotherapy for Patients With Inoperable Malignant Central Airway Obstruction",
"has_exemption": false,
"start_date": "2024-10-01",
"completion_date": "2029-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05956821",
"publication_url": "https://clinicaltrials.gov/study/NCT05956821",
"title": "Phase I/II Trial of Repeat Dosing of Super-Selective Intraarterial Infusion of Erbitux (Cetuximab) and Avastin (Bevacizumab) for Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age",
"has_exemption": false,
"start_date": "2025-06-19",
"completion_date": "2029-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07246863",
"publication_url": "https://clinicaltrials.gov/study/NCT07246863",
"title": "Ph 2, Randomized, Blinded, Placebo-Controlled Trial Investigating the Efficacy and Safety of Visugromab and Nivolumab With or Without Docetaxel Versus Docetaxel in 2L Treatment of Participants With Metastatic NSCLC (GDFATHER-NSCLC-02)",
"has_exemption": false,
"start_date": "2025-10-07",
"completion_date": "2029-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "CatalYm GmbH",
"sponsor_slug": "catalym-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07128199",
"publication_url": "https://clinicaltrials.gov/study/NCT07128199",
"title": "A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus Adjuvant Chemotherapy Versus Placebo Plus Adjuvant Chemotherapy in Stage IB-IIIA NSCLC Patients With Uncommon EGFR Mutations Following Complete Tumor Resection (REZILIENT4)",
"has_exemption": false,
"start_date": "2025-12-22",
"completion_date": "2029-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Taiho Oncology, Inc.",
"sponsor_slug": "taiho-oncology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07593859",
"publication_url": "https://clinicaltrials.gov/study/NCT07593859",
"title": "Overcoming the Barriers to Effective Transcranial Temporal Interference Stimulation in Humans",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2029-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Northeastern University",
"sponsor_slug": "northeastern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07283705",
"publication_url": "https://clinicaltrials.gov/study/NCT07283705",
"title": "A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer",
"has_exemption": false,
"start_date": "2026-04-09",
"completion_date": "2029-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06093425",
"publication_url": "https://clinicaltrials.gov/study/NCT06093425",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled Study Evaluating Combination of TST001, Pembrolizumab and Chemotherapy as First-Line Treatment in Subjects With Claudin18.2 Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Suzhou Transcenta Therapeutics Co., Ltd.",
"sponsor_slug": "suzhou-transcenta-therapeutics-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05935761",
"publication_url": "https://clinicaltrials.gov/study/NCT05935761",
"title": "Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II Trial",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2029-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07763210",
"publication_url": "https://clinicaltrials.gov/study/NCT07763210",
"title": "A Phase 2 Trial of Early Enhanced Interventions to Prevent ICANS After CD19 CAR T Therapy in Patients With Non-Hodgkin Lymphoma: Lazarus Trial",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2029-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt-Ingram Cancer Center",
"sponsor_slug": "vanderbilt-ingram-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04871607",
"publication_url": "https://clinicaltrials.gov/study/NCT04871607",
"title": "A Phase 2 Trial of Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy (aTac-BEAM) Conditioning for Autologous Hematopoietic Cell Transplantation (AHCT) in Patients With Primary Refractory or Relapsed Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2021-11-02",
"completion_date": "2029-10-02",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07115043",
"publication_url": "https://clinicaltrials.gov/study/NCT07115043",
"title": "A Phase I/II Open-label Dose Escalation and Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD6750, a CD8 Guided IL-2 Agent Alone and in Combination With Other Anti-cancer Agents in Participants With Select Advanced or Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2025-07-29",
"completion_date": "2029-10-02",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06859099",
"publication_url": "https://clinicaltrials.gov/study/NCT06859099",
"title": "Long-term Extension Study to Evaluate the Safety and Efficacy of Riliprubart (SAR445088) in Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2029-10-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03552016",
"publication_url": "https://clinicaltrials.gov/study/NCT03552016",
"title": "Evaluation of Progression of Myopia in Children Treated With Vitamin B2 and Outdoor Sunlight Exposure",
"has_exemption": false,
"start_date": "2018-10-10",
"completion_date": "2029-10-10",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Missouri-Columbia",
"sponsor_slug": "university-of-missouri-columbia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06848088",
"publication_url": "https://clinicaltrials.gov/study/NCT06848088",
"title": "Extended Follow-up of Patients With Melanoma Treated With Fianlimab Plus Cemiplimab in Expansion Cohorts From Study R3767-ONC-1613",
"has_exemption": false,
"start_date": "2025-04-14",
"completion_date": "2029-10-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07539441",
"publication_url": "https://clinicaltrials.gov/study/NCT07539441",
"title": "Phase 1/2 Trial of Mirdametinib in Patients With MAPK Pathway Mutant Central Nervous System Tumors",
"has_exemption": false,
"start_date": "2026-04-10",
"completion_date": "2029-10-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07518745",
"publication_url": "https://clinicaltrials.gov/study/NCT07518745",
"title": "Mapping Transcrnial Magnetic Stimulation (TMS) Responses Within the Brain Using Intracranial Electrophysiological Monitoring Recordings",
"has_exemption": false,
"start_date": "2025-11-11",
"completion_date": "2029-10-11",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06979453",
"publication_url": "https://clinicaltrials.gov/study/NCT06979453",
"title": "A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Deucravacitinib in Adolescent Participants (12 Years to Less Than 18 Years) With Moderate to Severe Plaque Psoriasis",
"has_exemption": false,
"start_date": "2025-12-03",
"completion_date": "2029-10-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04908709",
"publication_url": "https://clinicaltrials.gov/study/NCT04908709",
"title": "Spectroscopic MRI Guided Proton Therapy for Pediatric High-Grade Glioma (RAD4500)",
"has_exemption": false,
"start_date": "2018-12-20",
"completion_date": "2029-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07291076",
"publication_url": "https://clinicaltrials.gov/study/NCT07291076",
"title": "ROSETTA HCC-206: An Open-Label, Multi-Center, Randomized Phase 1/2 Study of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC)",
"has_exemption": false,
"start_date": "2026-03-16",
"completion_date": "2029-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07365306",
"publication_url": "https://clinicaltrials.gov/study/NCT07365306",
"title": "A Phase 2 Study of Epcoritamab-R-GemOx With Consolidative ASCT and Additional Epcoritamab in Relapsed/Refractory Transplant-Eligible DLBCL",
"has_exemption": false,
"start_date": "2026-04-15",
"completion_date": "2029-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06428409",
"publication_url": "https://clinicaltrials.gov/study/NCT06428409",
"title": "A Phase 1/2 Study to Evaluate the Safety and Efficacy of MK-2870 Monotherapy or in Combination With Other Anticancer Agents in Gastrointestinal Cancers",
"has_exemption": false,
"start_date": "2024-06-20",
"completion_date": "2029-10-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07549412",
"publication_url": "https://clinicaltrials.gov/study/NCT07549412",
"title": "A Randomized, Open Label, 3-arm Phase 3 Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)",
"has_exemption": false,
"start_date": "2026-05-06",
"completion_date": "2029-10-16",
"has_results": false,
"results_due": false,
"sponsor_name": "EMD Serono Research & Development Institute, Inc.",
"sponsor_slug": "emd-serono-research-development-institute-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04094090",
"publication_url": "https://clinicaltrials.gov/study/NCT04094090",
"title": "Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia",
"has_exemption": false,
"start_date": "2019-10-19",
"completion_date": "2029-10-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Goodman Eye Center",
"sponsor_slug": "goodman-eye-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07194980",
"publication_url": "https://clinicaltrials.gov/study/NCT07194980",
"title": "Safety and Efficacy of the Addition of Nemtabrutinib to Lisocabtagene Maraleucel in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2029-10-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07275216",
"publication_url": "https://clinicaltrials.gov/study/NCT07275216",
"title": "Phase 2 Study of Pembrolizumab With Chemotherapy in Frail Patients With Newly Diagnosed Classical Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2029-10-20",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04708041",
"publication_url": "https://clinicaltrials.gov/study/NCT04708041",
"title": "A Phase 3 International, Multicenter, Open-label Study to Evaluate the Safety and Immunogenicity of 9vHPV Vaccine Administered as 2-dose Regimen With Extended Dosing Intervals in 9- to 14-Year Old Boys and Girls Compared With a Standard 3-dose Regimen in 16- to 26-Year Old Women",
"has_exemption": false,
"start_date": "2021-03-15",
"completion_date": "2029-10-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04144972",
"publication_url": "https://clinicaltrials.gov/study/NCT04144972",
"title": "Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain Using Summit RC+S",
"has_exemption": false,
"start_date": "2019-10-24",
"completion_date": "2029-10-24",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05933577",
"publication_url": "https://clinicaltrials.gov/study/NCT05933577",
"title": "A Phase 3, Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled Clinical Study of Adjuvant V940 (mRNA-4157) Plus Pembrolizumab Versus Adjuvant Placebo Plus Pembrolizumab in Participants With High-Risk Stage II-IV Melanoma (INTerpath-001)",
"has_exemption": false,
"start_date": "2023-07-19",
"completion_date": "2029-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06704269",
"publication_url": "https://clinicaltrials.gov/study/NCT06704269",
"title": "An Open-label, Multi-center, Phase I/II Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Participants With Treatment-resistant Generalized Myasthenia Gravis",
"has_exemption": false,
"start_date": "2025-04-22",
"completion_date": "2029-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07000357",
"publication_url": "https://clinicaltrials.gov/study/NCT07000357",
"title": "A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Effect of AZD0780 on Major Adverse Cardiovascular Events in Patients With Established Atherosclerotic Cardiovascular Disease (ASCVD) or at High Risk for a First ASCVD Event",
"has_exemption": false,
"start_date": "2025-06-04",
"completion_date": "2029-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07773727",
"publication_url": "https://clinicaltrials.gov/study/NCT07773727",
"title": "A Phase 2, Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of ARGX-121 SC in Adult Participants With Primary IgA Nephropathy",
"has_exemption": false,
"start_date": "2026-10-15",
"completion_date": "2029-10-29",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04419649",
"publication_url": "https://clinicaltrials.gov/study/NCT04419649",
"title": "A Phase 2, Open-Label, Ascending Dose Study of KER-050 for the Treatment of Anemia in Patients With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)",
"has_exemption": false,
"start_date": "2020-08-19",
"completion_date": "2029-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05187338",
"publication_url": "https://clinicaltrials.gov/study/NCT05187338",
"title": "Triplex CTLA4/PD1/PDL1 Checkpoint Inhibitors Combination Therapy for Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2021-11-01",
"completion_date": "2029-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Second Affiliated Hospital of Guangzhou Medical University",
"sponsor_slug": "second-affiliated-hospital-of-guangzhou-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06513962",
"publication_url": "https://clinicaltrials.gov/study/NCT06513962",
"title": "Triptorelin and Protection of Ovarian Reserve in Adolescents and Young Adults With Cancer",
"has_exemption": false,
"start_date": "2025-02-27",
"completion_date": "2029-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07342478",
"publication_url": "https://clinicaltrials.gov/study/NCT07342478",
"title": "A Phase 3 Open-Label, Randomized, Multicenter Study of Rocbrutinib (LP-168) vs Pirtobrutinib in Covalent BTK Inhibitor (cBTKi) Pretreated Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) Subjects",
"has_exemption": false,
"start_date": "2026-04-23",
"completion_date": "2029-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Newave Pharmaceutical Inc",
"sponsor_slug": "newave-pharmaceutical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07551856",
"publication_url": "https://clinicaltrials.gov/study/NCT07551856",
"title": "Manual Arthroplasty Versus VELYS Robotic-Assisted Solution Functional Alignment Arthroplasty for Knee Osteoarthritis (The MARVEL Project): A Pragmatic, Multicentre, Blinded Randomised Controlled Trial With Multi-domain Investigations",
"has_exemption": false,
"start_date": "2026-05-08",
"completion_date": "2029-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Golden Jubilee National Hospital",
"sponsor_slug": "golden-jubilee-national-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07681596",
"publication_url": "https://clinicaltrials.gov/study/NCT07681596",
"title": "A Modular, Phase I/II, Open-label, Multicentre Study to Evaluate the Safety, Tolerability, Cellular Kinetics, and Efficacy of AZD4045, an Allogeneic Chimeric Antigen Receptor-T Cell (CAR-T) Therapy Targeting B Cell Maturation Antigen (BCMA) in Participants With Relapsed or Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2026-07-09",
"completion_date": "2029-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07412704",
"publication_url": "https://clinicaltrials.gov/study/NCT07412704",
"title": "A Phase 1/2a, Open-label, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of BMS-986528 in Participants With Refractory Rheumatoid Arthritis",
"has_exemption": false,
"start_date": "2026-09-15",
"completion_date": "2029-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00887146",
"publication_url": "https://clinicaltrials.gov/study/NCT00887146",
"title": "Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma",
"has_exemption": false,
"start_date": "2009-09-30",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Alliance for Clinical Trials in Oncology",
"sponsor_slug": "alliance-for-clinical-trials-in-oncology",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04587128",
"publication_url": "https://clinicaltrials.gov/study/NCT04587128",
"title": "Phase II Trial of Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2020-10-19",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05894343",
"publication_url": "https://clinicaltrials.gov/study/NCT05894343",
"title": "Long-term Follow-up of Glutamic Acid Decarboxylase Gene Transfer to the Subthalamic Nuclei in Participants With Parkinson's Disease",
"has_exemption": false,
"start_date": "2023-05-19",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "MeiraGTx, LLC",
"sponsor_slug": "meiragtx-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05903092",
"publication_url": "https://clinicaltrials.gov/study/NCT05903092",
"title": "A Phase II Trial of MOnaliZumab in Combination With durvAlumab (MEDI4736) for tReatmenT of Small Cell Lung Cancer (MOZART)",
"has_exemption": false,
"start_date": "2023-09-26",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hirva Mamdani",
"sponsor_slug": "hirva-mamdani",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05800743",
"publication_url": "https://clinicaltrials.gov/study/NCT05800743",
"title": "Evaluation of the GORE® Ascending Stent Graft in the Treatment of Lesions of the Ascending Aorta",
"has_exemption": false,
"start_date": "2023-11-28",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "W.L.Gore & Associates",
"sponsor_slug": "wlgore-associates",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06529731",
"publication_url": "https://clinicaltrials.gov/study/NCT06529731",
"title": "A Phase 2 Trial of Interferon-γ (IFN-γ) in Combination With Donor Leukocyte Infusion (DLI) to Treat Relapsed Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) After Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT)",
"has_exemption": false,
"start_date": "2024-09-23",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sawa Ito, MD",
"sponsor_slug": "sawa-ito-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06649539",
"publication_url": "https://clinicaltrials.gov/study/NCT06649539",
"title": "Efficacy of a Step-wise Protocol in Optimizing CCH Outcomes in Men With Peyronie's Disease",
"has_exemption": false,
"start_date": "2024-10-11",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Charitable Union for the Research and Education of Peyronie's Disease",
"sponsor_slug": "charitable-union-for-the-research-and-education-of-peyronies-disease",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06619561",
"publication_url": "https://clinicaltrials.gov/study/NCT06619561",
"title": "A Phase 2, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, PK, and Efficacy of Vimseltinib in Adults With Active Chronic GVHD After Failure of Prior Systemic Therapy",
"has_exemption": false,
"start_date": "2024-11-21",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Deciphera Pharmaceuticals LLC",
"sponsor_slug": "deciphera-pharmaceuticals-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06558214",
"publication_url": "https://clinicaltrials.gov/study/NCT06558214",
"title": "OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial",
"has_exemption": false,
"start_date": "2024-12-10",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06789445",
"publication_url": "https://clinicaltrials.gov/study/NCT06789445",
"title": "A Phase 1/2a Study of Subretinal Administration of OpCT-001 Photoreceptor Precursor Cells Derived From iPSCs in Patients With Primary Photoreceptor Disease",
"has_exemption": false,
"start_date": "2025-03-10",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BlueRock Therapeutics",
"sponsor_slug": "bluerock-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06635889",
"publication_url": "https://clinicaltrials.gov/study/NCT06635889",
"title": "Double-Blind Randomized Placebo Controlled Trial of Intravesical Bupivacaine on Post-Operative Ureteroscopy Pain",
"has_exemption": false,
"start_date": "2025-03-26",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06801834",
"publication_url": "https://clinicaltrials.gov/study/NCT06801834",
"title": "A Global, Multicenter, Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Standard of Care (SOC) in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer (ES-SCLC)",
"has_exemption": false,
"start_date": "2025-04-04",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06577714",
"publication_url": "https://clinicaltrials.gov/study/NCT06577714",
"title": "Ablation Guided Via Precision Imaging Using Electromechanical Wave Imaging",
"has_exemption": false,
"start_date": "2025-04-15",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Columbia University",
"sponsor_slug": "columbia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06990867",
"publication_url": "https://clinicaltrials.gov/study/NCT06990867",
"title": "Optimizing Reperfusion to Improve Outcomes and Neurologic Function (ORION): A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Phase 2/3 Study to Evaluate the Efficacy and Safety of JX10 in Acute Ischemic Stroke With Late Presentations",
"has_exemption": false,
"start_date": "2025-05-15",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Corxel Pharmaceuticals",
"sponsor_slug": "corxel-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06418178",
"publication_url": "https://clinicaltrials.gov/study/NCT06418178",
"title": "A Dose Optimization Study of MDMA-Assisted Therapy for PTSD in U.S. Veterans",
"has_exemption": false,
"start_date": "2025-06-03",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Bronx VA Medical Center",
"sponsor_slug": "bronx-va-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06909565",
"publication_url": "https://clinicaltrials.gov/study/NCT06909565",
"title": "Evaluation of Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention (V-INTERVENTION)",
"has_exemption": false,
"start_date": "2025-07-23",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07160179",
"publication_url": "https://clinicaltrials.gov/study/NCT07160179",
"title": "Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of ABBV-6628 in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration",
"has_exemption": false,
"start_date": "2025-08-13",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06639282",
"publication_url": "https://clinicaltrials.gov/study/NCT06639282",
"title": "SIPO1-AD: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Siponimod in Patients With Mild Alzheimer's Disease",
"has_exemption": false,
"start_date": "2025-08-26",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Joseph's Hospital and Medical Center, Phoenix",
"sponsor_slug": "st-josephs-hospital-and-medical-center-phoenix",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06718751",
"publication_url": "https://clinicaltrials.gov/study/NCT06718751",
"title": "Tranexamic Acid Therapy For The Treatment of Subdural Hematomas",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor College of Medicine",
"sponsor_slug": "baylor-college-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07193550",
"publication_url": "https://clinicaltrials.gov/study/NCT07193550",
"title": "A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)",
"has_exemption": false,
"start_date": "2025-12-05",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218380",
"publication_url": "https://clinicaltrials.gov/study/NCT07218380",
"title": "FORAGER-2: A Phase 3, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Vepugratinib Combined With Enfortumab Vedotin and Pembrolizumab in Adults With Untreated Locally Advanced or Metastatic Urothelial Carcinoma With an FGFR3 Genetic Alteration",
"has_exemption": false,
"start_date": "2025-12-12",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06898970",
"publication_url": "https://clinicaltrials.gov/study/NCT06898970",
"title": "An Open-Label, Multicenter, Phase 2 Study With Safety Lead-In of Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab in Patients With Angiosarcoma",
"has_exemption": false,
"start_date": "2026-01-09",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Varun Monga, MBBS",
"sponsor_slug": "varun-monga-mbbs",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06975111",
"publication_url": "https://clinicaltrials.gov/study/NCT06975111",
"title": "Focusing on the Menopausal Transition to Improve Mid-Life Women's Health",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07325513",
"publication_url": "https://clinicaltrials.gov/study/NCT07325513",
"title": "Machine Learning in Guiding rTMS Treatment for GWI-Related Headaches and Body Pain",
"has_exemption": false,
"start_date": "2026-03-25",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Veterans Medical Research Foundation",
"sponsor_slug": "veterans-medical-research-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07368985",
"publication_url": "https://clinicaltrials.gov/study/NCT07368985",
"title": "A Phase II Single Arm Open Label Study of Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer: an EMBRACE High Risk Study Initiative",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Prof. Dr. Remi A. Nout",
"sponsor_slug": "prof-dr-remi-a-nout",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07175051",
"publication_url": "https://clinicaltrials.gov/study/NCT07175051",
"title": "Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin",
"has_exemption": false,
"start_date": "2026-04-08",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221214",
"publication_url": "https://clinicaltrials.gov/study/NCT07221214",
"title": "GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV - GL1DER HIV RCT",
"has_exemption": false,
"start_date": "2026-04-17",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07419334",
"publication_url": "https://clinicaltrials.gov/study/NCT07419334",
"title": "A Phase 3 Multicenter, Double-Masked, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, and Efficacy of Gildeuretinol Acetate (ALK 001) on the Progression of Stargardt Disease (STGD)",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Alkeus Pharmaceuticals, Inc.",
"sponsor_slug": "alkeus-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07441889",
"publication_url": "https://clinicaltrials.gov/study/NCT07441889",
"title": "Phase I/II Study of Anti-CD3 x Anti-HER2 Bispecific Antibody (HER2Bi) Armed Fresh Peripheral Blood Mononuclear Cells (HER2 FPBMC) in Metastatic Castrate Resistant Prostate Cancer (mCRPC) and Metastatic Breast Cancer (MBC)",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07516093",
"publication_url": "https://clinicaltrials.gov/study/NCT07516093",
"title": "A Phase 3, Randomized, Open-label, Multicenter Study of NX-5948 Versus Pirtobrutinib in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nurix Therapeutics, Inc.",
"sponsor_slug": "nurix-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07777822",
"publication_url": "https://clinicaltrials.gov/study/NCT07777822",
"title": "A Randomized, Double-blind, Phase 3 Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib (RMC-9805) as First Line Treatment in Patients With Metastatic Non-squamous RAS G12D-Mutated Non-small Cell Lung Cancer (RASolve 308)",
"has_exemption": false,
"start_date": "2026-08-14",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Revolution Medicines, Inc.",
"sponsor_slug": "revolution-medicines-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07637578",
"publication_url": "https://clinicaltrials.gov/study/NCT07637578",
"title": "A Phase II, Nonrandomized, Single-Arm Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma (CORE-MM)",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SCRI Development Innovations, LLC",
"sponsor_slug": "scri-development-innovations-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06697496",
"publication_url": "https://clinicaltrials.gov/study/NCT06697496",
"title": "Navigation and Artificial Intelligence Technology for Indigenous Virtual Education on Smoking Cessation (NAITIVE)",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07744126",
"publication_url": "https://clinicaltrials.gov/study/NCT07744126",
"title": "A Phase 2 Open-Label Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination With Pembrolizumab as First-Line Treatment in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07767500",
"publication_url": "https://clinicaltrials.gov/study/NCT07767500",
"title": "A Phase II Single-Arm Study Evaluating Toxicity, Outcomes, and Dosimetry Using an MR-guided Linear Accelerator for the Treatment of Early Stage Kidney Cancer",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07680166",
"publication_url": "https://clinicaltrials.gov/study/NCT07680166",
"title": "A Seamless, Adaptive Multiple-Ascending-Dose and Efficacy Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations",
"has_exemption": false,
"start_date": "2026-10-30",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Xentria, Inc.",
"sponsor_slug": "xentria-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07663487",
"publication_url": "https://clinicaltrials.gov/study/NCT07663487",
"title": "A Prospective, Multicenter, Open-label Two Cohort Study Evaluating the Safety and Efficacy of Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres to Bridge or Downstage Patients With Hepatocellular Carcinoma (HCC) to Liver Transplant or Resection and Elicit Pathologic Necrosis.",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sirtex Medical",
"sponsor_slug": "sirtex-medical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07773987",
"publication_url": "https://clinicaltrials.gov/study/NCT07773987",
"title": "Immunotherapy and Nodal-Sparing Irradiation for T-Cell Induction and Unmasking of Tumor Antigenicity in the Microenvironment for Head and Neck Cancer",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213960",
"publication_url": "https://clinicaltrials.gov/study/NCT07213960",
"title": "A Sequential Phase 2/3, Single-Arm, Open-Label Study in Adults Followed by a Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of APL2 in Adults and Adolescents With Focal Segmental Glomerulosclerosis",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Apellis Pharmaceuticals, Inc.",
"sponsor_slug": "apellis-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04865939",
"publication_url": "https://clinicaltrials.gov/study/NCT04865939",
"title": "A Randomized Trial Comparing Intravesical Gemcitabine to Continuous Bladder Irrigation With Sterile Water to Prevent Bladder Cancer Implantation in Patients Undergoing Excision of Upper Tract Urothelial Carcinoma",
"has_exemption": false,
"start_date": "2021-11-29",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05538663",
"publication_url": "https://clinicaltrials.gov/study/NCT05538663",
"title": "A Randomized Phase III Trial of Intravesical BCG veRsus Intravesical Docetaxel and GEmcitabine Treatment in BCG Naïve High Grade Non-Muscle Invasive Bladder Cancer (BRIDGE)",
"has_exemption": false,
"start_date": "2023-02-07",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06854003",
"publication_url": "https://clinicaltrials.gov/study/NCT06854003",
"title": "A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma",
"has_exemption": false,
"start_date": "2025-04-22",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Christine Ryan",
"sponsor_slug": "christine-ryan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07115940",
"publication_url": "https://clinicaltrials.gov/study/NCT07115940",
"title": "Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well - SELECT LATE Trial",
"has_exemption": false,
"start_date": "2026-04-13",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Amrou Sarraj",
"sponsor_slug": "amrou-sarraj",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07269470",
"publication_url": "https://clinicaltrials.gov/study/NCT07269470",
"title": "Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase",
"has_exemption": false,
"start_date": "2026-07-13",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07715006",
"publication_url": "https://clinicaltrials.gov/study/NCT07715006",
"title": "Dorsal Root Electrical Stimulation to Suppress Spastic Muscle Activation in Children With Cerebral Palsy",
"has_exemption": false,
"start_date": "2026-07-16",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Martin Piazza",
"sponsor_slug": "martin-piazza",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07720167",
"publication_url": "https://clinicaltrials.gov/study/NCT07720167",
"title": "Neoadjuvant Chemo-Cemiplimab for Clinical Stage I, 2-3.9cm, Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07768631",
"publication_url": "https://clinicaltrials.gov/study/NCT07768631",
"title": "A Prospective, Multicenter, Randomized, Sham-Controlled Study Evaluating the Metabolic Effects of pulsENDO Therapy in Adults With Type 2 Diabetes (pULSENDO Study)",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Endogenex, Inc.",
"sponsor_slug": "endogenex-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04665206",
"publication_url": "https://clinicaltrials.gov/study/NCT04665206",
"title": "Phase I/II, Multi-Center, Open-Label Study of VT3989, Alone or in Combination, in Patients With Locally Advanced or Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2021-03-24",
"completion_date": "2029-11-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Vivace Therapeutics, Inc",
"sponsor_slug": "vivace-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07206056",
"publication_url": "https://clinicaltrials.gov/study/NCT07206056",
"title": "TulmiSTAR-01: A Two-part, Phase I Dose Escalation and Expansion Followed by a Randomized, Open-label Multicenter, Phase II Study to Assess the Safety and Efficacy of the Combination of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) vs Standard of Care in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2029-11-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07518238",
"publication_url": "https://clinicaltrials.gov/study/NCT07518238",
"title": "Comparative Effectiveness of Bupivacaine-Dexamethasone-Epinephrine Versus Exparel in Postoperative Outcomes for Hernia Patients Undergoing Abdominal Wall Reconstruction",
"has_exemption": false,
"start_date": "2026-01-13",
"completion_date": "2029-11-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor Research Institute",
"sponsor_slug": "baylor-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06698003",
"publication_url": "https://clinicaltrials.gov/study/NCT06698003",
"title": "A Phase 2 Study for Screening and Prevention of Adult T-cell Leukemia/Lymphoma With Mogamulizumab in High-Risk Carriers of HTLV-1",
"has_exemption": false,
"start_date": "2024-11-15",
"completion_date": "2029-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07052942",
"publication_url": "https://clinicaltrials.gov/study/NCT07052942",
"title": "Individualizing Treatment for Asthma in Primary Care (Full Study)",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2029-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "DARTNet Institute",
"sponsor_slug": "dartnet-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00117936",
"publication_url": "https://clinicaltrials.gov/study/NCT00117936",
"title": "Human Recombinant Fibroblast Growth Factor-1 (FGF-1), for the Treatment of Subjects With Severe Coronary Heart Disease, a Placebo Controlled, Double-blind, Dose-varying Study",
"has_exemption": false,
"start_date": "2027-09-01",
"completion_date": "2029-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Venturis Therapeutics, Inc.",
"sponsor_slug": "venturis-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06315322",
"publication_url": "https://clinicaltrials.gov/study/NCT06315322",
"title": "A MULTICENTER, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE LONG-TERM SAFETY AND TOLERABILITY OF BRIVARACETAM IN STUDY PARTICIPANTS WITH CHILDHOOD ABSENCE EPILEPSY OR JUVENILE ABSENCE EPILEPSY",
"has_exemption": false,
"start_date": "2024-07-10",
"completion_date": "2029-11-16",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05526755",
"publication_url": "https://clinicaltrials.gov/study/NCT05526755",
"title": "An Open-label, Single-arm, Phase II, Multinational, Multicentre Study to Assess the Efficacy and Safety of 5 Years of Osimertinib in Participants With EGFRm-positive Stage II-IIIB NSCLC, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy",
"has_exemption": false,
"start_date": "2023-03-06",
"completion_date": "2029-11-22",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07441408",
"publication_url": "https://clinicaltrials.gov/study/NCT07441408",
"title": "An Open-label, Multi-center, Long-term Extension Study to Evaluate the Long-term Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis",
"has_exemption": false,
"start_date": "2026-12-16",
"completion_date": "2029-11-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05636618",
"publication_url": "https://clinicaltrials.gov/study/NCT05636618",
"title": "A Phase I/IIa First-in-Human Study of [212Pb]VMT-α-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Tumors",
"has_exemption": false,
"start_date": "2023-09-27",
"completion_date": "2029-11-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Perspective Therapeutics",
"sponsor_slug": "perspective-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07190209",
"publication_url": "https://clinicaltrials.gov/study/NCT07190209",
"title": "A Phase 2b/Phase 3, Randomized, Double-blind, Placebocontrolled, Multicenter Study, to Investigate the Efficacy and Safety of Lunsekimig in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype",
"has_exemption": false,
"start_date": "2025-09-16",
"completion_date": "2029-11-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07190222",
"publication_url": "https://clinicaltrials.gov/study/NCT07190222",
"title": "A Phase 2b/Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study, to Investigate the Efficacy and Safety of Lunsekimig in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype",
"has_exemption": false,
"start_date": "2025-09-17",
"completion_date": "2029-11-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07293351",
"publication_url": "https://clinicaltrials.gov/study/NCT07293351",
"title": "ROSETTA RCC-208: A Phase 1/2 Open-label, Multi-center, Randomized Study of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC)",
"has_exemption": false,
"start_date": "2026-03-26",
"completion_date": "2029-11-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06008756",
"publication_url": "https://clinicaltrials.gov/study/NCT06008756",
"title": "Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascular Events in Participants at High Cardiovascular Risk",
"has_exemption": false,
"start_date": "2023-10-09",
"completion_date": "2029-11-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07187401",
"publication_url": "https://clinicaltrials.gov/study/NCT07187401",
"title": "A Randomized, Double-Blind, Placebo-Controlled, First-In-Human Study of the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ALN-CFB, an Investigational siRNA Therapeutic Against Complement Factor B, in Participants With Paroxysmal Nocturnal Hemoglobinuria and Persistent Anemia on Approved C5-Inhibitor Therapy",
"has_exemption": false,
"start_date": "2026-02-11",
"completion_date": "2029-11-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03769766",
"publication_url": "https://clinicaltrials.gov/study/NCT03769766",
"title": "A Randomized, Double-Blind, Placebo-Controlled Trial of Curcumin to Prevent Progression of Biopsy Proven, Low-risk Localized Prostate Cancer Patients Undergoing Active Surveillance",
"has_exemption": false,
"start_date": "2019-03-11",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04408625",
"publication_url": "https://clinicaltrials.gov/study/NCT04408625",
"title": "A Phase 1/2 Ascending Dose Study to Evaluate the Safety and Effects on Progranulin Levels of LY3884963 in Patients With Fronto-Temporal Dementia With Progranulin Mutations (FTD-GRN)",
"has_exemption": false,
"start_date": "2020-11-09",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Prevail Therapeutics",
"sponsor_slug": "prevail-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05533775",
"publication_url": "https://clinicaltrials.gov/study/NCT05533775",
"title": "A Phase I/II, Open-Label, Single-Arm, Two-Part Trial to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination With Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2022-11-16",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03762395",
"publication_url": "https://clinicaltrials.gov/study/NCT03762395",
"title": "Anti Inflammatory Lipid Mediators in Asthma: A Double Blind Placebo Control Cross Over, Proof of Concept Study of CXA-10 to Reduce Bronchial Hyperresponsiveness in Obese Asthmatics; Lipid Anti-Inflammatory Mediators in Asthma to Reduce Hyperresponsiveness in Obese Asthmatics",
"has_exemption": false,
"start_date": "2023-02-08",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06163430",
"publication_url": "https://clinicaltrials.gov/study/NCT06163430",
"title": "A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia",
"has_exemption": false,
"start_date": "2024-03-26",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)",
"sponsor_slug": "terns-inc-a-subsidiary-of-merck-co-inc-rahway-new-jersey-usa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05796908",
"publication_url": "https://clinicaltrials.gov/study/NCT05796908",
"title": "A Prospective, Multi-Center, Single-Arm Clinical Trial of the Safety and Effectiveness of the Aptis PRUJ Prosthesis for the Treatment of Patients With Proximal Radial Ulna Joint Disorders.",
"has_exemption": false,
"start_date": "2024-04-12",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Aptis Medical",
"sponsor_slug": "aptis-medical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05998031",
"publication_url": "https://clinicaltrials.gov/study/NCT05998031",
"title": "A Mechanistic Study to Investigate tDCS and Working Memory in MCI Patients",
"has_exemption": false,
"start_date": "2024-04-24",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06951906",
"publication_url": "https://clinicaltrials.gov/study/NCT06951906",
"title": "Imaging Biomarkers of Freezing of Gait Response to Deep Brain Stimulation",
"has_exemption": false,
"start_date": "2024-11-11",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06399263",
"publication_url": "https://clinicaltrials.gov/study/NCT06399263",
"title": "Study of Psilocybin for Anorexia in Young Adults",
"has_exemption": false,
"start_date": "2024-11-18",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Marissa Raymond-Flesch, MD, MPH",
"sponsor_slug": "marissa-raymond-flesch-md-mph",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06697184",
"publication_url": "https://clinicaltrials.gov/study/NCT06697184",
"title": "A Phase 1/2 Open-label Study to Investigate the Safety of Sonrotoclax Ramp-up Schedule(s) in Adult Patients With Hematological Malignancies.",
"has_exemption": false,
"start_date": "2025-01-23",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BeOne Medicines",
"sponsor_slug": "beone-medicines",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06679634",
"publication_url": "https://clinicaltrials.gov/study/NCT06679634",
"title": "Retinoblastoma Phase II Expanded Access Clinical Trial",
"has_exemption": false,
"start_date": "2025-02-21",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Targeted Therapy Technologies, LLC",
"sponsor_slug": "targeted-therapy-technologies-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06589804",
"publication_url": "https://clinicaltrials.gov/study/NCT06589804",
"title": "Randomized Phase III Trial of Pembrolizumab vs. Pembrolizumab/Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma With Platinum Refractory Disease",
"has_exemption": false,
"start_date": "2025-03-27",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06668493",
"publication_url": "https://clinicaltrials.gov/study/NCT06668493",
"title": "A Phase 1/2, Single-arm, Open-Label Trial to Evaluate the Safety and Efficacy of Nadofaragene Firadenovec Instilled to the Renal Pelvis in Adult Subjects With Low-grade Upper Tract Urothelial Carcinoma (LG-UTUC)",
"has_exemption": false,
"start_date": "2025-06-12",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ferring Pharmaceuticals",
"sponsor_slug": "ferring-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07023289",
"publication_url": "https://clinicaltrials.gov/study/NCT07023289",
"title": "A Phase 2, Randomized, Open-Label Study Comparing Telisotuzumab Adizutecan (ABBV-400) Monotherapy to the Current Standard of Care in Subjects With Post Adjuvant ctDNA Positive Colorectal Cancer and No Radiographic Evidence of Disease (NED)",
"has_exemption": false,
"start_date": "2025-09-02",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07069738",
"publication_url": "https://clinicaltrials.gov/study/NCT07069738",
"title": "Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure",
"has_exemption": false,
"start_date": "2025-10-22",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Scientific Corporation",
"sponsor_slug": "boston-scientific-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07207369",
"publication_url": "https://clinicaltrials.gov/study/NCT07207369",
"title": "A Multicenter, Cohort-design, Double-blind, Randomized, Parallel-group, Controlled Study to Evaluate the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars",
"has_exemption": false,
"start_date": "2025-10-24",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07095868",
"publication_url": "https://clinicaltrials.gov/study/NCT07095868",
"title": "A Phase I/IIa Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 as Monotherapy and in Combination With Pembrolizumab in Patients With Selected Solid Tumors",
"has_exemption": false,
"start_date": "2025-11-17",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Everest Medicines (Beijing) Co., Ltd.",
"sponsor_slug": "everest-medicines-beijing-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07188805",
"publication_url": "https://clinicaltrials.gov/study/NCT07188805",
"title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Investigate the Efficacy, Safety, and PK/ PD of Finerenone, in Addition to Standard-of-care, in Pediatric Patients, 6 Months to < 18 Years of Age With Heart Failure (HF) and Left Ventricular Systolic Dysfunction (LVSD)",
"has_exemption": false,
"start_date": "2025-11-19",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bayer",
"sponsor_slug": "bayer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284290",
"publication_url": "https://clinicaltrials.gov/study/NCT07284290",
"title": "Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia",
"has_exemption": false,
"start_date": "2025-12-08",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07398157",
"publication_url": "https://clinicaltrials.gov/study/NCT07398157",
"title": "Subgaleal Cortical Electrodes in Patients With Parkinson's Disease Undergoing Deep-brain Stimulation Therapy for Sensing and Adaptive Deep-brain Stimulation Over a 24-hour Period.",
"has_exemption": false,
"start_date": "2026-04-09",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07429240",
"publication_url": "https://clinicaltrials.gov/study/NCT07429240",
"title": "A Phase 1/2a, Multi-center, Open-label Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of PBGENE-DMD in Participants With Duchenne Muscular Dystrophy (FUNCTION-DMD)",
"has_exemption": false,
"start_date": "2026-04-24",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Precision BioSciences, Inc.",
"sponsor_slug": "precision-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07188896",
"publication_url": "https://clinicaltrials.gov/study/NCT07188896",
"title": "A Randomized Phase 2 Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)",
"has_exemption": false,
"start_date": "2026-04-29",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Brian Rini",
"sponsor_slug": "brian-rini",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06224673",
"publication_url": "https://clinicaltrials.gov/study/NCT06224673",
"title": "Phase II Open-label Study of ARX788 (Anti-HER2 Antibody Drug Conjugate (ADC)) for Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer",
"has_exemption": false,
"start_date": "2026-06-05",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Laura Huppert, MD, BA",
"sponsor_slug": "laura-huppert-md-ba",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07179315",
"publication_url": "https://clinicaltrials.gov/study/NCT07179315",
"title": "A Randomized Phase II Trial of Cemiplimab With or Without Fianlimab in Patients With Detectable Minimal-residual Disease After Definitive Treatment for Human Papillomavirus Positive HPV(+) Head and Neck Cancer.",
"has_exemption": false,
"start_date": "2026-06-09",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07216391",
"publication_url": "https://clinicaltrials.gov/study/NCT07216391",
"title": "Adaptive Platform Trial to Delay Progression From Stage 2 to Stage 3 Type 1 Diabetes: Comparing Teplizumab With Low-dose Anti-Thymocyte Globulin (ATG) Protocol TN-40A",
"has_exemption": false,
"start_date": "2026-07-30",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07171489",
"publication_url": "https://clinicaltrials.gov/study/NCT07171489",
"title": "An Early Feasibility Study of Using the AccelBand, a Leg-worn Transcutaneous Neuromodulation (TNM) Device, for Neurogenic Bowel Dysfunction (NBD) in People With Spinal Cord Injury (SCI)",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07722182",
"publication_url": "https://clinicaltrials.gov/study/NCT07722182",
"title": "A Pragmatic Randomised Trial Comparing Navigation Bronchoscopy-guided Microwave Ablation Versus Stereotactic Body Radiotherapy for Medically Inoperable or Surgery-declining Early-stage Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-08-10",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Chinese University of Hong Kong",
"sponsor_slug": "chinese-university-of-hong-kong",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07688577",
"publication_url": "https://clinicaltrials.gov/study/NCT07688577",
"title": "A First-in-Human, Multicenter, Phase 1/2, Open-Label Study of XTX501 in Participants With Metastatic Non-Small Cell Lung Cancer and Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Xilio Development, Inc.",
"sponsor_slug": "xilio-development-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07772024",
"publication_url": "https://clinicaltrials.gov/study/NCT07772024",
"title": "A Phase 3, Multicenter, Open-Label, Randomized Study to Evaluate Inobrodib in Combination With Pomalidomide and Dexamethasone Versus Standard Available Therapy in Patients With Relapsed or Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "CellCentric Ltd.",
"sponsor_slug": "cellcentric-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07606664",
"publication_url": "https://clinicaltrials.gov/study/NCT07606664",
"title": "Fezolinetant and Vascular Health and Brain Health",
"has_exemption": false,
"start_date": "2026-09-25",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rebecca Thurston",
"sponsor_slug": "rebecca-thurston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07094542",
"publication_url": "https://clinicaltrials.gov/study/NCT07094542",
"title": "Temporo-masseteric Nerve Block in Post-wisdom Tooth Extraction Pain- a Randomized Study",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rutgers, The State University of New Jersey",
"sponsor_slug": "rutgers-the-state-university-of-new-jersey",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07342439",
"publication_url": "https://clinicaltrials.gov/study/NCT07342439",
"title": "Phase 3 Study of Serine Supplementation to Protect Vision in MacTel",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The Lowy Medical Research Institute Limited",
"sponsor_slug": "the-lowy-medical-research-institute-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00610051",
"publication_url": "https://clinicaltrials.gov/study/NCT00610051",
"title": "Phase 3 Study of Alprostadil Continuous Intravenous Infusion to Maintain Clinical Stability in Severe Heart Failure Patients",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Biopeutics Co., Ltd",
"sponsor_slug": "biopeutics-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04414917",
"publication_url": "https://clinicaltrials.gov/study/NCT04414917",
"title": "Reducing Opioid Use/Misuse Through Better Pain Control and Active Pill Dispensing",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rutgers, The State University of New Jersey",
"sponsor_slug": "rutgers-the-state-university-of-new-jersey",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06660862",
"publication_url": "https://clinicaltrials.gov/study/NCT06660862",
"title": "DAROSTEP: Evaluating Step Counts as a Biomarker and Its Relationship on Treatment Outcomes in Vulnerable Patients With Metastatic Hormone-Sensitive Prostate Cancer on Darolutamide and Androgen Deprivation Therapy",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01581580",
"publication_url": "https://clinicaltrials.gov/study/NCT01581580",
"title": "Deep Brain Stimulation Surgery for Movement Disorders",
"has_exemption": false,
"start_date": "2011-08-17",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Neurological Disorders and Stroke (NINDS)",
"sponsor_slug": "national-institute-of-neurological-disorders-and-stroke-ninds",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04374305",
"publication_url": "https://clinicaltrials.gov/study/NCT04374305",
"title": "Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)",
"has_exemption": false,
"start_date": "2020-06-20",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Scott R. Plotkin, MD, PhD",
"sponsor_slug": "scott-r-plotkin-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04532424",
"publication_url": "https://clinicaltrials.gov/study/NCT04532424",
"title": "Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD",
"has_exemption": false,
"start_date": "2021-01-04",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04240054",
"publication_url": "https://clinicaltrials.gov/study/NCT04240054",
"title": "A Multisite, Phase II Study of Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone (VICD) Induction in Transplant-Eligible Multiple Myeloma Patients With Renal Insufficiency",
"has_exemption": false,
"start_date": "2021-11-02",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05154669",
"publication_url": "https://clinicaltrials.gov/study/NCT05154669",
"title": "Integrating Financial Coaching and Smoking Cessation Coaching for People With Low Income Who Smoke: a Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2022-12-08",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06043817",
"publication_url": "https://clinicaltrials.gov/study/NCT06043817",
"title": "First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations",
"has_exemption": false,
"start_date": "2023-09-26",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Pierre Fabre Medicament",
"sponsor_slug": "pierre-fabre-medicament",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06447103",
"publication_url": "https://clinicaltrials.gov/study/NCT06447103",
"title": "89Zr-DFO-GmAb PET/CT vs Contrast-Enhanced CT for Detection of Recurrent Clear Cell Renal Cell Carcinoma After Surgery",
"has_exemption": false,
"start_date": "2024-08-06",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06739356",
"publication_url": "https://clinicaltrials.gov/study/NCT06739356",
"title": "North American Fetal Therapy Network Prospective Registry for Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia",
"has_exemption": false,
"start_date": "2025-03-04",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05766839",
"publication_url": "https://clinicaltrials.gov/study/NCT05766839",
"title": "A 2-Part, Open-Label, Phase 2, Multiple Dose Study to Evaluate the Pharmacodynamic Effects, Safety, and Tolerability of Patiromer in Children Under 12 Years of Age With Hyperkalaemia (EMERALD2)",
"has_exemption": false,
"start_date": "2025-04-06",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Vifor Pharma, Inc.",
"sponsor_slug": "vifor-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07166172",
"publication_url": "https://clinicaltrials.gov/study/NCT07166172",
"title": "North American Fetal Therapy Network Prospective Registry for Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia",
"has_exemption": false,
"start_date": "2025-06-23",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07483294",
"publication_url": "https://clinicaltrials.gov/study/NCT07483294",
"title": "Cerebellar-cortical Circuitry and Prediction of Treatment Response in Early Psychosis",
"has_exemption": false,
"start_date": "2025-11-01",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwell Health",
"sponsor_slug": "northwell-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222215",
"publication_url": "https://clinicaltrials.gov/study/NCT07222215",
"title": "A Phase II Multi-Center Open-label Randomized Study of CAPecitabine in Combination With ELAcestrant Versus Capecitabine Alone in Advanced Estrogen Receptor-Positive Breast Cancer (CAPELA)",
"has_exemption": false,
"start_date": "2026-01-16",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Kristina A. Fanucci",
"sponsor_slug": "kristina-a-fanucci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07096778",
"publication_url": "https://clinicaltrials.gov/study/NCT07096778",
"title": "A Phase II, Open-Label, Multicenter Study of Inobrodib in Combination With Pomalidomide and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2026-01-22",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "CellCentric Ltd.",
"sponsor_slug": "cellcentric-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07502872",
"publication_url": "https://clinicaltrials.gov/study/NCT07502872",
"title": "TPG: a Phase 2 Trial of Polatuzumab Vedotin, Glofitamab, and Tafasitamab as Chemotherapy-sparing First-line Therapy for Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brown University",
"sponsor_slug": "brown-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07510607",
"publication_url": "https://clinicaltrials.gov/study/NCT07510607",
"title": "Assessing Metabolic Changes in Multiple Sclerosis Using Hyper-polarized Carbon 13 MRI",
"has_exemption": false,
"start_date": "2026-06-03",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Ari Green",
"sponsor_slug": "ari-green",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07721493",
"publication_url": "https://clinicaltrials.gov/study/NCT07721493",
"title": "An Assessment of the Safety and Effectiveness of the CORUS™ Posterior Cervical Stabilization System 3D (PCSS 3D) to Determine Superiority to ANterior Cervical Discectomy and Fusion (ACDF) in the Treatment of 2-Level Cervical Degenerative Disease",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Providence Medical Technology, Inc.",
"sponsor_slug": "providence-medical-technology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06552000",
"publication_url": "https://clinicaltrials.gov/study/NCT06552000",
"title": "Phase 0 Trial of Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06854029",
"publication_url": "https://clinicaltrials.gov/study/NCT06854029",
"title": "Optimizing Long-Acting Pre-Exposure Prophylaxis and Medications for Opioid Use Disorder Interventions in Carceral Settings",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07296094",
"publication_url": "https://clinicaltrials.gov/study/NCT07296094",
"title": "Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder: A Double-Blind, Dose-Comparison Concurrent Control Randomized Trial",
"has_exemption": false,
"start_date": "2026-08-15",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07690891",
"publication_url": "https://clinicaltrials.gov/study/NCT07690891",
"title": "Phase II Study of Nemtabrutinib With Venetoclax and Obinutuzumab in Patients With Chronic Lymphocytic Leukemia",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05479643",
"publication_url": "https://clinicaltrials.gov/study/NCT05479643",
"title": "A Pilot Study for a Novel and Personalized Voice Restoration Device for Patients With Laryngectomy",
"has_exemption": false,
"start_date": "2027-12-01",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05130437",
"publication_url": "https://clinicaltrials.gov/study/NCT05130437",
"title": "A Phase 1/2, Global, Open-Label, Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study",
"has_exemption": false,
"start_date": "2021-11-09",
"completion_date": "2029-12-04",
"has_results": false,
"results_due": false,
"sponsor_name": "ModernaTX, Inc.",
"sponsor_slug": "modernatx-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06449651",
"publication_url": "https://clinicaltrials.gov/study/NCT06449651",
"title": "Double-blind, Randomized, Placebo-controlled Study Evaluating the Safety and Efficacy of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) in At-risk Pregnancies",
"has_exemption": false,
"start_date": "2024-11-11",
"completion_date": "2029-12-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07190248",
"publication_url": "https://clinicaltrials.gov/study/NCT07190248",
"title": "A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084 in Combination With Subcutaneous Pembrolizumab and Berahyaluronidase Alfa (MK-3475A) Versus MK-3475A in Combination With Pemetrexed/Platinum (Carboplatin or Cisplatin) Chemotherapy as First-line Treatment of Participants With KRAS G12C-Mutant, Advanced or Metastatic Nonsquamous NSCLC (KANDLELIT-007)",
"has_exemption": false,
"start_date": "2025-10-08",
"completion_date": "2029-12-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07623161",
"publication_url": "https://clinicaltrials.gov/study/NCT07623161",
"title": "A Phase 3, Double-Blind, Randomized Trial Evaluating the Efficacy and Safety of Elritercept (TAK-226) Compared to Placebo in Participants With Myelofibrosis and Anemia on Concurrent Ruxolitinib Therapy",
"has_exemption": false,
"start_date": "2026-08-25",
"completion_date": "2029-12-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04938817",
"publication_url": "https://clinicaltrials.gov/study/NCT04938817",
"title": "A Phase 1b/2 Study to Evaluate the Efficacy and Safety of Investigational Agents as Monotherapy or in Combination With Pembrolizumab for the Treatment of Participants With PD-1/L1-refractory Extensive-Stage Small Cell Lung Cancer in Need of Second-Line Therapy (KEYNOTE-B98)",
"has_exemption": false,
"start_date": "2021-08-19",
"completion_date": "2029-12-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06804642",
"publication_url": "https://clinicaltrials.gov/study/NCT06804642",
"title": "Rehabilitation of Locomotor Function in Parkinson's Disease by Non-invasive Spinal Cord Stimulation",
"has_exemption": false,
"start_date": "2024-12-12",
"completion_date": "2029-12-11",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Louisville",
"sponsor_slug": "university-of-louisville",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06747949",
"publication_url": "https://clinicaltrials.gov/study/NCT06747949",
"title": "A Multicenter, Open-Label, Long-term, Extension Study to Evaluate the Safety and Tolerability of Dazodalibep in Participants With Sjögren's Syndrome (SS)",
"has_exemption": false,
"start_date": "2025-02-25",
"completion_date": "2029-12-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07508982",
"publication_url": "https://clinicaltrials.gov/study/NCT07508982",
"title": "Phase1b/2 Trial Of AZA + APG1252 In Patients With High-Risk AML",
"has_exemption": false,
"start_date": "2026-05-22",
"completion_date": "2029-12-12",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07740720",
"publication_url": "https://clinicaltrials.gov/study/NCT07740720",
"title": "A Phase 3b, Open-label Study Investigating the Duration of Neoadjuvant Dostarlimab Monotherapy in Participants With Untreated Stage II/III dMMR/MSI-H Locally Advanced Rectal Cancer",
"has_exemption": false,
"start_date": "2026-09-17",
"completion_date": "2029-12-12",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06652438",
"publication_url": "https://clinicaltrials.gov/study/NCT06652438",
"title": "Randomized Study to Assess Revumenib in Combination With Azacitidine + Venetoclax in Adult Patients With Newly Diagnosed NPM1-mutated or KMT2A-rearranged AML Ineligible for Intensive Chemotherapy",
"has_exemption": false,
"start_date": "2025-05-05",
"completion_date": "2029-12-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Stichting Hemato-Oncologie voor Volwassenen Nederland",
"sponsor_slug": "stichting-hemato-oncologie-voor-volwassenen-nederland",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07544654",
"publication_url": "https://clinicaltrials.gov/study/NCT07544654",
"title": "A Phase III, Multi-center, Open-label, Randomised, Controlled Trial of Intravenous Obrixtamig in Combination With Carboplatin and Etoposide vs. Carboplatin and Etoposide as First-line Therapy in DLL3-positive Patients With Unresectable Locally Advanced or Metastatic Extrapulmonary Neuroendocrine Carcinomas",
"has_exemption": false,
"start_date": "2026-07-10",
"completion_date": "2029-12-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07064473",
"publication_url": "https://clinicaltrials.gov/study/NCT07064473",
"title": "EASi-PROTKT™ - A Phase III Double-blind, Randomised, Parallel-group Superiority Trial to Evaluate Efficacy and Safety of the Combined Use of Oral Vicadrostat (BI 690517) and Empagliflozin Compared With Placebo and Empagliflozin in Participants With Type 2 Diabetes, Hypertension and Established Cardiovascular Disease",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2029-12-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06101290",
"publication_url": "https://clinicaltrials.gov/study/NCT06101290",
"title": "Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)",
"has_exemption": false,
"start_date": "2023-12-05",
"completion_date": "2029-12-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Davis",
"sponsor_slug": "university-of-california-davis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06677060",
"publication_url": "https://clinicaltrials.gov/study/NCT06677060",
"title": "A Phase III, Randomised, Placebo-controlled, Event-driven Study to Evaluate the Effect of Baxdrostat in Combination With Dapagliflozin Compared With Dapagliflozin Alone on the Risk of Incident Heart Failure and Cardiovascular Death",
"has_exemption": false,
"start_date": "2025-03-14",
"completion_date": "2029-12-17",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07286266",
"publication_url": "https://clinicaltrials.gov/study/NCT07286266",
"title": "A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants With Platinum-resistant Ovarian Cancer",
"has_exemption": false,
"start_date": "2026-06-18",
"completion_date": "2029-12-17",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06380751",
"publication_url": "https://clinicaltrials.gov/study/NCT06380751",
"title": "A Randomised, Open-Label, Phase III Study of Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With Physician's Choice CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant for the First-Line Treatment of Patients With BRCA1, BRCA2, or PALB2 Mutations and Hormone Receptor Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified) Advanced Breast Cancer (EvoPAR-Breast01)",
"has_exemption": false,
"start_date": "2024-08-01",
"completion_date": "2029-12-18",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06542250",
"publication_url": "https://clinicaltrials.gov/study/NCT06542250",
"title": "A Modular Phase I/II Open-label Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With Relapsed or Refractory B-Cell Malignancies (TITANium)",
"has_exemption": false,
"start_date": "2024-09-18",
"completion_date": "2029-12-18",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06742723",
"publication_url": "https://clinicaltrials.gov/study/NCT06742723",
"title": "A Phase III, Randomised, Double-blind, Placebo-controlled, Event-driven Study to Assess the Efficacy, Safety and Tolerability of Baxdrostat in Combination With Dapagliflozin Compared With Dapagliflozin Alone on Renal Outcomes and Cardiovascular Mortality in Participants With Chronic Kidney Disease and High Blood Pressure",
"has_exemption": false,
"start_date": "2025-03-03",
"completion_date": "2029-12-18",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07288567",
"publication_url": "https://clinicaltrials.gov/study/NCT07288567",
"title": "A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (13 to 17 Years of Age)",
"has_exemption": false,
"start_date": "2026-01-29",
"completion_date": "2029-12-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07286058",
"publication_url": "https://clinicaltrials.gov/study/NCT07286058",
"title": "A Phase 3, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of Zasocitinib (TAK-279) in Subjects With Active Psoriatic Arthritis Who Are Either Biologic DMARD-Naïve or Biologic DMARD-Experienced, Including Those With Inadequate Response to Biologic DMARDs",
"has_exemption": false,
"start_date": "2026-03-11",
"completion_date": "2029-12-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07579429",
"publication_url": "https://clinicaltrials.gov/study/NCT07579429",
"title": "Research On Nicotinamide Riboside Supplement Support in MDS (ROSS Trial)",
"has_exemption": false,
"start_date": "2026-05-20",
"completion_date": "2029-12-18",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07700056",
"publication_url": "https://clinicaltrials.gov/study/NCT07700056",
"title": "A 52-week Multi-center, Randomized, Double-blind, Placebo Controlled Phase 3 Study to Evaluate the Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)",
"has_exemption": false,
"start_date": "2026-08-14",
"completion_date": "2029-12-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03684018",
"publication_url": "https://clinicaltrials.gov/study/NCT03684018",
"title": "Randomized Study of Two Dose Levels of Privigen in Pediatric CIDP",
"has_exemption": false,
"start_date": "2019-02-28",
"completion_date": "2029-12-20",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04684368",
"publication_url": "https://clinicaltrials.gov/study/NCT04684368",
"title": "A Phase 2 Trial of Chemotherapy Followed by Response-Based Whole Ventricular &Amp; Spinal Canal Irradiation (WVSCI) for Patients With Localized Non-Germinomatous Central Nervous System Germ Cell Tumor",
"has_exemption": false,
"start_date": "2021-07-13",
"completion_date": "2029-12-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06907147",
"publication_url": "https://clinicaltrials.gov/study/NCT06907147",
"title": "Global Pilot Study of rEnal and Hepatic coMbINed denervatIon in Subjects With Uncontrolled Hypertension With and Without High Cardiovascular Risk",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2029-12-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Medtronic Vascular",
"sponsor_slug": "medtronic-vascular",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05844982",
"publication_url": "https://clinicaltrials.gov/study/NCT05844982",
"title": "A Trial Evaluating Intravitreal Faricimab (6.0 mg) Injections or Fluocinolone Acetonide (0.19 mg Intravitreal Implants vs Observation for Prevention of Visual Acuity Loss Due to Radiation Retinopathy",
"has_exemption": false,
"start_date": "2023-11-21",
"completion_date": "2029-12-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Jaeb Center for Health Research",
"sponsor_slug": "jaeb-center-for-health-research",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07459504",
"publication_url": "https://clinicaltrials.gov/study/NCT07459504",
"title": "A Sequential Multiple Assignment Randomized Trial of Diet Treatments for Hepatic Steatosis and Cardiometabolic Risk in Youth",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-12-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Michigan State University",
"sponsor_slug": "michigan-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04924075",
"publication_url": "https://clinicaltrials.gov/study/NCT04924075",
"title": "A Phase 2 Study to Evaluate the Efficacy and Safety of Belzutifan (MK-6482, Formerly PT2977) Monotherapy in Participants With Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Advanced Solid Tumors With HIF-2α Related Genetic Alterations",
"has_exemption": false,
"start_date": "2021-08-12",
"completion_date": "2029-12-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06716606",
"publication_url": "https://clinicaltrials.gov/study/NCT06716606",
"title": "An Open Label Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD)",
"has_exemption": false,
"start_date": "2024-12-12",
"completion_date": "2029-12-27",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06357533",
"publication_url": "https://clinicaltrials.gov/study/NCT06357533",
"title": "A Phase III, Randomised, Open-label, Global Study of Datopotamab Deruxtecan (Dato-DXd) in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Pembrolizumab Monotherapy for the First-line Treatment of Participants With Locally-advanced or Metastatic Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations (TROPION-Lung10)",
"has_exemption": false,
"start_date": "2024-04-11",
"completion_date": "2029-12-28",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07770815",
"publication_url": "https://clinicaltrials.gov/study/NCT07770815",
"title": "A Phase 3, Open-label, Single-arm, Repeat-dose Trial to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Sibeprenlimab Administered Subcutaneously in Children and Adolescents With Immunoglobulin A Nephropathy",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-12-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Otsuka Pharmaceutical Development & Commercialization, Inc.",
"sponsor_slug": "otsuka-pharmaceutical-development-commercialization-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03458429",
"publication_url": "https://clinicaltrials.gov/study/NCT03458429",
"title": "Safety and Efficacy of GMFFP From Young Healthy Donors (18-35), Treated With G-CSF to Ameliorate Frailty and Enhance the Immune Risk Profile in Older Individuals",
"has_exemption": false,
"start_date": "2018-02-05",
"completion_date": "2029-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Dipnarine Maharaj",
"sponsor_slug": "dipnarine-maharaj",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05910801",
"publication_url": "https://clinicaltrials.gov/study/NCT05910801",
"title": "Tafasitamab, Lenalidomide and Venetoclax Combination Therapy for Relapsed or Refractory Mantle Cell Lymphoma (V-MIND): a Phase II Study with Safety Lead-In",
"has_exemption": false,
"start_date": "2024-01-04",
"completion_date": "2029-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Academic and Community Cancer Research United",
"sponsor_slug": "academic-and-community-cancer-research-united",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06764615",
"publication_url": "https://clinicaltrials.gov/study/NCT06764615",
"title": "A Phase 2, Open-Label Extension Trial to Evaluate the Long-term Safety and Tolerability of Oral Zasocitinib (TAK-279) in Participants With Moderately to Severely Active Ulcerative Colitis and Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2025-05-28",
"completion_date": "2029-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05569486",
"publication_url": "https://clinicaltrials.gov/study/NCT05569486",
"title": "Elucidating the Central Mechanism(s) of Action for Green Light Therapy in Managing Chronic Pain",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2029-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arizona",
"sponsor_slug": "university-of-arizona",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00262470",
"publication_url": "https://clinicaltrials.gov/study/NCT00262470",
"title": "Treatment of Orthostatic Intolerance",
"has_exemption": false,
"start_date": "1997-04-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Satish R. Raj",
"sponsor_slug": "satish-r-raj",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT00900497",
"publication_url": "https://clinicaltrials.gov/study/NCT00900497",
"title": "A Phase I/II Study For the Use of White Blood Cells From Healthy Donor-participants To Treat Subjects With Solid Cancers",
"has_exemption": false,
"start_date": "2009-04-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dipnarine Maharaj",
"sponsor_slug": "dipnarine-maharaj",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01841723",
"publication_url": "https://clinicaltrials.gov/study/NCT01841723",
"title": "A Multicenter Phase 2 Study of the Bruton's Tyrosine Kinase Inhibitor PCI-32765 (Ibrutinib) for Treatment of Relapsed Hairy Cell Leukemia",
"has_exemption": false,
"start_date": "2013-04-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02582697",
"publication_url": "https://clinicaltrials.gov/study/NCT02582697",
"title": "Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours",
"has_exemption": false,
"start_date": "2014-02-28",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Sydney",
"sponsor_slug": "university-of-sydney",
"status": "ongoing",
"is_pact": true,
"days_late": null
}
]
}